Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Germinoma × Bleomycin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Hodgkin Disease 28 Lymphoma 15 Lymphoma, Large B-Cell, Diffuse 5 Vulvar Neoplasms 3 Neoplasms, Germ Cell and Embryonal 3 Lymphoma, Follicular 3 Neoplasms 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Large-Cell, Immunoblastic 2 Dendritic Cell Sarcoma, Interdigitating 2 Warts 1 Ulcer 1 Testicular Neoplasms 1 Stomach Neoplasms 1 Skin Neoplasms 1 Seminoma 1 Recurrence 1 Rectal Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pathologic Processes 1 Ovarian Neoplasms 1 Ovarian Germ Cell Cancer 1 Neoplastic Processes 1 Neoplasms, Second Primary 1 Neoplasm Metastasis 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Mantle-Cell 1 Intracranial Non-germinomatous Germ Cell Tumor 1 Hemangioma, Capillary 1 Hemangioma 1

Interventions

Etoposide 2 Carboplatin 2 tremelimumab 1 etoposide phosphate 1 durvalumab 1 Photochemotherapy 1 Paclitaxel 1 Ifosfamide 1 Granulocyte Colony-Stimulating Factor 1 Drug Therapy 1 Dihematoporphyrin Ether 1 Cyclophosphamide 1 Cisplatin 1 Bleomycin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02782754 2016-05-25

Chemotherapy Plus Reduced Radiotherapy in Intracranial Germinoma

Samsung Medical Center

Phase 2 Unknown

Germinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡